Pramipexole

dopamine receptor D2 ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34810175 PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. 2022 May 1
2 35605609 Enhanced taste recognition following subacute treatment with the dopamine D2/D3 receptor agonist pramipexole in healthy volunteers. 2022 May 23 1
3 33264473 Dopamine and ghrelin receptor co-expression and interaction in the spinal defecation centers. 2021 May 1
4 34451897 An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers. 2021 Aug 14 1
5 31235613 Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke. 2019 Aug 29 1
6 31324936 Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents. 2019 Aug 1
7 21408026 Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457. 2011 Mar 9 1
8 19396436 Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients. 2009 Jul 2
9 17161393 Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity. 2007 Feb 28 1
10 12737528 Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonists. 2003 Jul 1
11 10812530 Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. 2000 1
12 11054154 Pre-clinical studies of pramipexole: clinical relevance. 2000 May 1
13 10201413 Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. 1999 Apr 1
14 8665547 Pramipexole in patients with early Parkinson's disease. 1995 Aug 1
15 8748629 The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease. 1995 1